Published in Am J Trop Med Hyg on July 09, 2001
Impact of varicella vaccine on varicella-zoster virus dynamics. Clin Microbiol Rev (2010) 1.47
Toward universal varicella-zoster virus (VZV) genotyping: diversity of VZV strains from France and Spain. J Clin Microbiol (2006) 1.23
Seroprevalence of cytomegalovirus, Epstein Barr virus and varicella zoster virus among pregnant women in Bradford: a cohort study. PLoS One (2013) 1.00
Varicella-zoster virus (chickenpox) infection in pregnancy. BJOG (2011) 0.99
Hospitalizations for varicella in children and adolescents in a referral hospital in Hong Kong, 2004 to 2008: a time series study. BMC Public Health (2011) 0.98
Household size is critical to varicella-zoster virus transmission in the tropics despite lower viral infectivity. Epidemics (2010) 0.97
The seroepidemiology of varicella zoster virus among pregnant Bangladeshi and white British women in the London Borough of Tower Hamlets, UK. Epidemiol Infect (2007) 0.93
Varicella-zoster virus at relapses of multiple sclerosis. J Neurol (2007) 0.92
Varicella zoster virus infection. Nat Rev Dis Prim (2015) 0.90
Genotypic analysis of varicella-zoster virus and its seroprevalence in Finland. Clin Vaccine Immunol (2007) 0.88
Successes and challenges in varicella vaccine. Ther Adv Vaccines (2014) 0.86
Time trends in pediatric hospitalizations for varicella infection are associated with climatic changes: a 22-year retrospective study in a tertiary Greek referral center. PLoS One (2012) 0.84
Genetic analysis of clinical VZV isolates collected in China reveals a more homologous profile. Biomed Res Int (2013) 0.81
Human Herpesviruses as Copathogens of HIV Infection, Their Role in HIV Transmission, and Disease Progression. J Lab Physicians (2016) 0.81
Varicella immunity in Iran: an age-stratified systematic review and meta-analysis. Iran J Microbiol (2014) 0.79
Solar radiation and water vapor pressure to forecast chickenpox epidemics. Eur J Clin Microbiol Infect Dis (2014) 0.79
Meteorological conditions related to the onset of idiopathic sudden sensorineural hearing loss. Yonsei Med J (2014) 0.78
Is ultra-violet radiation the main force shaping molecular evolution of varicella-zoster virus? Virol J (2011) 0.78
Outbreak of chickenpox in a refugee camp of northern Thailand. Confl Health (2010) 0.76
Varicella seroprevalence in healthcare workers in a tertiary hospital: an audit of cross-sectional data. BMC Res Notes (2015) 0.76
Hidden varicella outbreak, Luang Prabang Province, the Lao People's Democratic Republic, December 2014 to January 2015. Western Pac Surveill Response J (2016) 0.75
Seroprevalence and Risk Factors of Varicella Zoster Infection in Iranian Adolescents: A Multilevel Analysis; The CASPIAN-III Study. PLoS One (2016) 0.75
Analysis of enzymatic digestion pattern of two open reading frames of Varciella-Zoster genome from Kuwaiti patients using the RFLP technique. Iran J Microbiol (2012) 0.75
Microbiology laboratory and the management of mother-child varicella-zoster virus infection. World J Virol (2016) 0.75
Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific. BMC Infect Dis (2017) 0.75
Sero-Prevalence of Antibodies against Varicella Zoster Virus in Children under Seven-Years Old in 2012 in Tehran, Iran. Iran J Public Health (2014) 0.75
Exposure rate of VZV among women attending antenatal care clinic in Sri Lanka - a cross sectional study. BMC Infect Dis (2017) 0.75
An aggressive case of PCR negative varicella zoster virus induced transverse myelitis. Neurol Sci (2014) 0.75
Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet (1994) 6.89
Recombination in bacteriophage lambda. I. Mutants deficient in general recombination. J Mol Biol (1968) 4.73
A unique set of polypeptides is induced by gamma interferon in addition to those induced in common with alpha and beta interferons. Nature (1983) 2.68
14C-urea breath analysis, a non-invasive test for Campylobacter pylori in the stomach. Lancet (1987) 2.68
Care of the dying cancer patient in the emergency department: findings from a National survey of Australian emergency department clinicians. Intern Med J (2014) 2.64
Recombination-deficient deletions in bacteriophage lambda and their interaction with chi mutations. Genetics (1975) 2.41
Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB J (1997) 2.33
Pertussis in adults: frequency of transmission after household exposure. Lancet (1995) 2.16
Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ (2008) 2.16
Biventricular repair of double outlet right ventricle with non-committed ventricular septal defect (VSD) by VSD rerouting to the pulmonary artery and arterial switch. Eur J Cardiothorac Surg (2002) 2.09
Recombination in bacteriophage lambda. II. Site-specific recombination promoted by the integration system. J Mol Biol (1968) 2.06
Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol Bioeng (2000) 1.96
Seroepidemiology of hepatitis A infection in India: changing pattern. Indian J Gastroenterol (2001) 1.82
Increased availability and open probability of single L-type calcium channels from failing compared with nonfailing human ventricle. Circulation (1998) 1.77
Bradycardia during sleep apnea. Characteristics and mechanism. J Clin Invest (1982) 1.74
Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement. FASEB J (2000) 1.74
Safety and reactogenicity of a low dose diphtheria tetanus acellular pertussis vaccine (Boostrix) in pre-school Indian children. Indian Pediatr (2007) 1.74
Deletion analysis of two nonessential regions of the T4 genome. Virology (1974) 1.70
CEA-related cell adhesion molecule 1: a potent angiogenic factor and a major effector of vascular endothelial growth factor. Mol Cell (2000) 1.63
Efficacy of acellular pertussis vaccine in early childhood after household exposure. JAMA (1996) 1.60
Ross and Ross-Konno procedure in children and adolescents: mid-term results. Eur J Cardiothorac Surg (2004) 1.57
The general recombination system of bacteriophage lambda. Cold Spring Harb Symp Quant Biol (1968) 1.54
Effects of oral pantoprazole on 24-hour intragastric acidity and plasma gastrin profiles. Aliment Pharmacol Ther (1992) 1.40
Alpha atrial natriuretic peptide concentrations in plasma of children with congenital heart and pulmonary diseases. Br Med J (Clin Res Ed) (1985) 1.40
Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomised, double-blind, controlled study. Vaccine (2009) 1.39
Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade. N Engl J Med (1970) 1.35
Site-specific recombination in bacteriophage lambda. Cold Spring Harb Symp Quant Biol (1968) 1.34
Predictors of early deterioration and mortality in black Americans with spontaneous intracerebral hemorrhage. Stroke (1995) 1.31
Activation of the coagulation cascade in severe falciparum malaria through the intrinsic pathway. Br J Haematol (1994) 1.30
Detection of delayed vaccinations: a new approach to visualize vaccine uptake. Epidemiol Infect (2002) 1.28
Recombination in bacteriophage lambda. 3. Studies on the nature of the prophage attachment region. J Mol Biol (1969) 1.27
"Eradication" of Campylobacter pylori: are we being misled? Lancet (1988) 1.26
Corticosteroids for treating dengue shock syndrome. Cochrane Database Syst Rev (2006) 1.25
Immunogenicity and safety of combined diphtheria tetanus whole cell pertussis hepatitis B/ Haemophilus influenzae type b vaccine in Indian infants. Indian Pediatr (2007) 1.25
Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age. Vaccine (2009) 1.22
Two three-month treatment regimens for pulmonary tuberculosis. Bull Int Union Tuberc (1976) 1.19
The nature and origin of a class of essential gene substitutions in bacteriophage lambda. Virology (1975) 1.19
Characteristics of lambda p4, a lambda derivative containing 9 per cent excess DNA. Virology (1972) 1.18
Age related seroprevalence of antibodies to varicella in India. Indian Pediatr (2000) 1.18
Reciprocal and non-reciprocal recombination in bacteriopahge lambda. J Mol Biol (1969) 1.16
Reinfection or recrudescence after apparently successful eradication of Helicobacter pylori infection: implications for treatment of patients with duodenal ulcer disease. Q J Med (1993) 1.15
Detection of partial anomalous pulmonary venous connection by magnetic resonance imaging. Pediatr Cardiol (2005) 1.13
Self expanding stents in congenital heart disease. Br Heart J (1994) 1.12
Bovine dilated cardiomyopathy: proteomic analysis of an animal model of human dilated cardiomyopathy. Electrophoresis (1999) 1.12
Helicobacter pylori infection in uraemic patients. Nephron (1991) 1.09
A mutant of Escherichia coli that prevents growth of phage lambda and is bypassed by lambda mutants in a nonessential region of the genome. Virology (1976) 1.09
Booster immunization of low- and non-responders after a standard three dose hepatitis B vaccine schedule--results of a post-marketing surveillance. Vaccine (1997) 1.05
Partial diploidy in phage T41. Genetics (1965) 1.01
[MRI in the diagnosis of non-compacted ventricular myocardium (NCVM) compared to echocardiography]. Rofo (2003) 0.95
Seroepidemiology of varicella-zoster in Pakistan. Southeast Asian J Trop Med Public Health (2000) 0.95
Symptoms and complications of pertussis in adults. Infection (1996) 0.93
The new DTPw-HBV-Hib combination vaccine can be used at the who schedule with a monovalent dose of hepatitis B vaccine at birth. Southeast Asian J Trop Med Public Health (1998) 0.93
Effectiveness of acellular pertussis vaccine assessed by hospital-based active surveillance in Germany. Clin Infect Dis (2002) 0.93
Functional implications of gene dosage effects in trisomy 21. Hum Genet Suppl (1981) 0.92
Influence of AV synchrony on the plasma levels of atrial natriuretic peptide (ANP) in patients with total AV block. Pacing Clin Electrophysiol (1988) 0.91
Influence of vaccination schedules and host factors on antibody response following hepatitis B vaccination. Eur J Clin Microbiol Infect Dis (1992) 0.90
Interferon induction of (2'-5') oligoisoadenylate synthetase in diploid and trisomy 21 human fibroblasts: relation to dosage of the interferon receptor gene (IRFC). Hum Genet (1983) 0.90
Endostatin inhibits angiogenesis by stabilization of newly formed endothelial tubes. Angiogenesis (2001) 0.90
A rotavirus vaccine for infants: the Asian experience. Ann Acad Med Singapore (2006) 0.90
Long-term persistence of anti-HAV antibodies following active immunization with hepatitis A vaccine. Vaccine (1997) 0.90
Trisomy 21: mechanisms and models. Ann N Y Acad Sci (1982) 0.90
The correlated occurrence of duplications and deletions in phage T4. Virology (1970) 0.89
Mechanisms of action of atrial natriuretic factor: clinical consequences. Klin Wochenschr (1986) 0.87
Comparison of plasma atrial natriuretic peptide levels in healthy children from birth to adolescence and in children with cardiac diseases. Pediatr Res (1986) 0.87
Immunogenicity and safety of an inactivated hepatitis A vaccine in anti-HIV positive and negative homosexual men. J Med Virol (1995) 0.87
The effect of trisomy 21 on the patterns of polypeptide synthesis in human fibroblasts. Am J Hum Genet (1979) 0.86
Hypoventilation in obstructive lung disease. The role of familial factors. N Engl J Med (1978) 0.86
Pertussis complications in Germany--3 years of hospital-based surveillance during the introduction of acellular vaccines. Infection (1998) 0.85
Helicobacter pylori and metronidazole resistance. Lancet (1990) 0.85
[Tuberculosis of the oesophagus (author's transl)]. Nouv Presse Med (1978) 0.84
Haemophilus influenzae type b disease: impact and effectiveness of diphtheria-tetanus toxoids-acellular pertussis (-inactivated poliovirus)/H. influenzae type b combination vaccines. Pediatr Infect Dis J (2001) 0.84
Inactivation of (Gialpha) proteins increases arrhythmogenic effects of beta-adrenergic stimulation in the heart. J Mol Cell Cardiol (1998) 0.84
Factors influencing the spread of pertussis in households. Eur J Pediatr (1998) 0.83
[Limitation of operability. What does the internist need to know?]. Internist (Berl) (2010) 0.83
Percutaneous closure of secundum atrial septal defect with a new self centering device ("angel wings"). Heart (1998) 0.82
Captopril in children with dilated cardiomyopathy: acute and long-term effects in a prospective study of hemodynamic and hormonal effects. Pediatr Cardiol (1990) 0.82
Comparison of the reactogenicity and immunogenicity of two different dose levels of hepatitis A vaccine in healthy children and adolescents. Asian Pac J Allergy Immunol (1999) 0.81
The efficacy of halofantrine in the treatment of acute malaria in nonimmune travelers. Am J Trop Med Hyg (1992) 0.81
Assessment of dry body-weight in haemodialysis patients by the biochemical marker cGMP. Nephrol Dial Transplant (1990) 0.81
Characterization of T4 mutants that partially suppress the inability of T4rII to grow in Lambda lysogens. Genetics (1976) 0.81
13C-urea breath test for Helicobacter pylori infection. Gut (1991) 0.81
[MRI of pulmonary arteries in follow-up after arterial-switch-operation (ASO) for transposition of great arteries (d-TGA)]. Rofo (2005) 0.81
Morphogenesis of lambda with genomes containing excess DNA: functional particles containing 12 and 15 per cent excess DNA. Virology (1975) 0.81
Does a previous course of tripotassium dicitrato bismuthate affect the subsequent chances of successful Helicobacter pylori eradication? Aliment Pharmacol Ther (1992) 0.81
Evidence for CCK(B) receptors in the guinea-pig kidney: localization and characterization by [125I]gastrin binding studies and by RT-PCR. Naunyn Schmiedebergs Arch Pharmacol (1998) 0.80
Myocardial viability assessed by positron emission tomography in infants and children after the arterial switch operation and suspected infarction. J Am Coll Cardiol (2000) 0.80
[MRI in postoperative assessment of univentricular heart disease: correlation with echocardiography and angiography]. Rofo (2002) 0.80
Concomitant administration of varicella vaccine with combined measles, mumps, and rubella vaccine in healthy children aged 12 to 24 months of age. Asian Pac J Allergy Immunol (2002) 0.80
Halofantrine: a new substance for treatment of multidrug-resistant malaria. Clin Investig (1993) 0.80
Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life. Vaccine (2006) 0.79
Is cyclic GMP a clinically useful marker for ANF action? Z Kardiol (1988) 0.79
A randomized comparative trial in order to assess the reactogenicity and immunogenicity of a new measles mumps rubella (MMR) vaccine when given as a first dose at 12-24 months of age. Southeast Asian J Trop Med Public Health (1999) 0.79
Verapamil impairs secretion of stimulated atrial natriuretic factor in humans. J Am Coll Cardiol (1988) 0.79
Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus, and tricomponent acellular pertussis vaccine at fourteen to twenty-eight months of age. J Pediatr (1997) 0.79
Synthesis of interferon-induced polypeptides in normal and chromosome 21-aneuploid human fibroblasts: relationship to relative sensitivities in antiviral assays. J Interferon Res (1980) 0.79
Replacement therapy for a homozygous protein C deficiency-state using a concentrate of human protein C and S. Br J Haematol (1988) 0.79